Hour24 News

Sophisticated and simple

NEWS

/

Medical News, Oncology

Jan 10, 2026

Medical News, Oncology /

Continued Zenocutuzumab Beyond Progression Shows Benefit in NRG1+ Pancreatic Cancer and Cholangiocarcinoma: eNRGy Trial Results at ASCO GI

New Insights from ASCO GI: Zenocutuzumab Beyond Progression New results from the eNRGy trial highlight a potential new path for patients with NRG1+ pancreatic cancer…